Genpharmasec Current Share Price | Genpharmasec Stock Screener
GENPHARMA
Trading & Distributors
Genpharmasec Current Stock Price Today
Live Share Price BSE
₹1.14
▲
0.02 (1.79%)
As of September 18, 2026, the live Genpharmasec share price (BSE: GENPHARMA) is ₹1.14, up 1.79% from the previous close, with shares trading between ₹1.11 and ₹1.14 in today's trading session, and a 52-week range of ₹0.78–₹2.02.
Browse Genpharmasec annual reports to support your investment research.
Use the Genpharmasec stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Genpharmasec Market Cap
₹64.75 Cr.
GENPHARMA P/E Ratio (TTM)
-
Genpharmasec P/B Ratio
0.97
EPS (TTM)
₹0.01
Dividend Yield
-
Debt to Equity
0.07
GENPHARMA 52 Week High
₹2.02
Genpharmasec 52 Week Low
₹0.78
Operating Margin
2.00%
Profit Margin
-
GENPHARMA Revenue (TTM)
₹50.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹138.00
Total Equity
₹66.00
Genpharmasec Current Share Price Chart
Track the current Genpharmasec share price and stock price with an interactive chart. Analyse GENPHARMA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Genpharmasec stock quote in one place.
Genpharmasec Company Profile - Fundamental Screener
Screen Genpharmasec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GENPHARMA shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE861N01036
Genpharmasec Balance Sheet Screener
Screen GENPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 138 | 80 | 71 | 20 |
| Current Assets | 81 | 27 | 41 | 19 |
| Fixed Assets | 23 | 8 | 1 | 0 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 26 | 5 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 66 | 65 | 65 | 15 |
| Share Capital | 55 | 55 | 55 | 28 |
| Reserves & Surplus | 11 | 10 | 9 | -12 |
Genpharmasec Income Statement Screener - Profit & Revenue Analysis
Screen Genpharmasec income statement and profit fundamentals.
Analyze GENPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genpharmasec share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50 | 57 | 41 | 33 | 13 | 15 | 9 | 7 | 6 | 11 | 7 | 8 | 6 | 6 |
| Expenses | 49 | 53 | 41 | 33 | 11 | 15 | 8 | 6 | 5 | 10 | 6 | 8 | 6 | 6 |
| EBITDA | 1 | 3 | 0 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 2.00% | 4.00% | -3.00% | -1.00% | 8.00% | -7.00% | 8.00% | 2.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 3.00% |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 2 | -1 | -1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 1 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | 0 | 1 | -1 | -1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| EPS | 0.00 | 0.02 | -0.02 | -0.02 | 0.02 | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 |
Genpharmasec Cash Flow Screener - Liquidity Fundamentals
Screen GENPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 3 | -3 | -3 |
| Investing Activities | -15 | -28 | 0 |
| Financing Activities | -1 | 48 | 3 |
| Net Cash Flow | -14 | 17 | 0 |
Genpharmasec Shareholding Pattern Screener
See Genpharmasec shareholding pattern with promoter, FII, and DII holdings.
Check Genpharmasec promoter holding and ownership changes for GENPHARMA on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 61.84% | 61.86% | 59.94% | 60.03% | 60.19% | 62.00% | 52.78% | 56.17% |
| Other Holding | 8.18% | 8.16% | 10.08% | 9.99% | 9.83% | 8.02% | 17.24% | 13.84% |
| Shareholder Count | 101,134 | 102,252 | 109,080 | 107,602 | 105,804 | 104,021 | 105,693 | 108,137 |
Genpharmasec Share Dividend Screener - Share Yield Analysis
Check Genpharmasec dividend history with payout and yield data.
View Genpharmasec dividend details including ex-dates and amounts for GENPHARMA stock.
Genpharmasec Stock Index Membership
See which indices include Genpharmasec stock.
Check GENPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genpharmasec Market Events Screener - Corporate Actions
Get Genpharmasec corporate actions including splits, bonuses, and buybacks.
Check Genpharmasec stock events that may affect GENPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -0.85% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 0.96% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | -3.36% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -2.59% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -11.30% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 1.04% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 9.27% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -11.46% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -6.05% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 10.55% |
| 2024-01-09 | 2024-01-09 | Rights | 1:1 | 82.23% |
| 2021-09-06 | 2021-09-06 | Change Of Name | NA | 0.00% |
Genpharmasec Competitors Screener - Peer Comparison
Screen GENPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 30,778 | 20.37 | 119,347 | 19.87% | 1,284 | 70.94 |
| MMTC | 9,288 | 20.88 | 181 | -31.28% | 387 | 41.74 |
| MSTC | 5,199 | 22.17 | 453 | 16.90% | 218 | 56.84 |
| Ravindra Energy | 3,090 | 51.76 | 543 | 107.17% | 84 | 44.15 |
| Vintage Coffee & Beverages | 2,540 | 32.90 | 553 | 76.98% | 72 | 57.66 |
| BN Agrochem | 2,004 | 114.51 | 874 | 137.94% | 34 | 22.19 |
| Creative Newtech | 1,677 | 21.96 | 2,700 | 49.86% | 70 | 44.60 |
| TCC Concept | 1,315 | 18.71 | 179 | 100.21% | 31 | 60.70 |
| Elitecon International | 1,308 | 3.71 | 551 | 55040.00% | 70 | 19.45 |
| Pervasive Commodities | 865 | 43 | 42.11% | 0 | 100.00 |
Genpharmasec Company Announcements - News Screener
Screen GENPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-14 | Reg. 34 (1) Annual Report. | - |
| 2026-09-14 | Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29 2026. | - |
| 2026-09-02 | Intimation Of Book Closure For The Purpose Of AGM | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-02 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday 02Nd September 2026. | - |
| 2026-09-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-31 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-28 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 02Nd September 2026. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June 2026. | - |
| 2026-08-11 | Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2026. | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday 11Th August 2026. | - |
| 2026-08-03 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 11Th August 2026. | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-27 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March 2026. | - |